Natural History of Brugada Syndrome: Insights for Risk Stratification and Management

By S. Priori, C. Napolitano, M. Gasparini, C. Pappone, P. Bella, U. Giordano, R. Bloise, C. Giustetto, Roberto De Nardis, Massimiliano Grillo and 3 more. Circulation, 2002

1,085 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/dee22432f987addb0cc9057131d633b69b367bfb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Molecular Biology

Douglas P. Zipes

Citations in the corpus

Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry (2010, background): “This could certainly explain in part the discrepancy between the different registries.(2,5,27) Until now, the only available treatment that has proven to prevent SCD in BrS patients is ICD implantation.”
ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). (2002, background): “(Level of Evidence: C) (157,158) New recommendation for ICD implantation in patients with the Brugada syndrome and syncope or family history of sudden cardiac death.”
HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. (2013, background): “[70, 72-78] The change probably reflects the inherent bias during the first years following the description of a novel disease, in which particularly severe forms of the disease are most likely to be diagnosed.”
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “VF occurs at a mean age of 41+ 15 years but it may manifest at any age, usually during rest or sleep.(451) Fever, excessive alcohol intake and large meals are triggers that unmask a type I”
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “Cardiac events (syncope or cardiac arrest) occur predominantly in males in the third and fourth decades of life, although presentation with cardiac arrest in neonates or children have been reported (104,777,820).”